Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the ...

A healthcare worker prepares a shot of the Pfizer COVID-19 vaccine in La Paz, Bolivia, Jan. 7. WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients ...

Strong financial position with cash, cash equivalents and marketable securities of $93.7M Moderna litigation U.S. trial scheduled for March ...

WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their immune systems to help fight tumors. People with advanced lung or skin ...

Pfizer Inc. announced updated follow-up results from the single-arm phase 2 PHAROS trial evaluating Braftovi (encorafenib) + Mektovi binimetinib) for the treatment of adults with metastatic non-small ...

Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating BRAFTOVI ® (encorafenib) + MEKTOVI ® (binimetinib) for the treatment of adults ...

Oct 18 (Reuters) - Pfizer (PFE.N), opens new tab and Japanese firm Astellas' (4503.T), opens new tab drug Padcev, combined with Merck's (MRK.N), opens new tab Keytruda, lowered the risk of tumor ...